Authors: | Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; Modi, S.; Troso-Sandoval, T.; Argolo, D.; Jack, K.; Ulaner, G.; Jochelson, M.; Baselga, J.; Norton, L.; Hudis, C. A.; Dang, C. T. |
Abstract Title: | Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy |
Meeting Title: | 2016 San Antonio Breast Cancer Symposium (SABCS) |
Journal Title: | Cancer Research |
Volume: | 77 |
Issue: | 4 Suppl. |
Meeting Dates: | 2016 Dec 6-10 |
Meeting Location: | San Antonio, TX |
ISSN: | 0008-5472 |
Publisher: | American Association for Cancer Research |
Date Published: | 2017-02-01 |
Language: | English |
ACCESSION: | WOS:000397999002002 |
DOI: | 10.1158/1538-7445.sabcs16-p4-21-34 |
PROVIDER: | wos |
Notes: | Meeting Abstract: P4-21-34 -- Source: Wos |